Psychiatric Digital Biomarkers Market Demand and Industry Growth Forecast 2026–2034
- Tanvi Shinde
- 3 hours ago
- 4 min read
The global Psychiatric Digital Biomarkers Market is witnessing rapid growth due to the increasing adoption of digital health technologies, rising prevalence of mental health disorders, growing demand for objective and continuous monitoring tools, and increasing investments in personalized healthcare. Advancements in artificial intelligence, wearable devices, smartphone-based monitoring, and digital therapeutics are further supporting market expansion.
According to Fortune Business Insights, the global Psychiatric Digital Biomarkers Market was valued at USD 797.85 billion in 2025 and is projected to grow from USD 995.8 billion in 2026 to USD 5,863.61 billion by 2034, exhibiting a CAGR of 24.81% during the forecast period.
Why is the Psychiatric Digital Biomarkers Market Growing Rapidly?
Psychiatric digital biomarkers are measurable physiological, behavioral, and cognitive data collected through digital technologies such as smartphones, wearable devices, sensors, and other connected platforms. These biomarkers can support the assessment, monitoring, and management of psychiatric conditions by providing continuous and objective data.
Growing awareness of mental health, increasing demand for early diagnosis, and the need for personalized treatment approaches are encouraging healthcare providers and researchers to adopt digital biomarkers. Unlike conventional assessments that often rely on periodic clinical evaluations and patient-reported information, digital biomarkers can provide real-world data over extended periods.
Psychiatric digital biomarkers are increasingly used in:
Depression monitoring
Anxiety disorder assessment
Schizophrenia management
Bipolar disorder monitoring
Cognitive health assessment
Behavioral health monitoring
Drug development and clinical trials
Personalized psychiatric care
Increasing adoption of digital healthcare solutions and growing investments in mental health technologies are expected to support long-term market growth.
Key Market Trends Shaping Industry Growth
Rising Adoption of Digital Health Technologies
Healthcare providers and researchers are increasingly adopting smartphones, wearable devices, activity trackers, and connected sensors to collect behavioral and physiological data. These technologies enable continuous monitoring and can provide valuable insights into changes in mood, sleep, activity, cognition, and other behavioral patterns.
For detailed market insights, visit the Psychiatric Digital Biomarkers Market Report:
Growing Demand for Objective Mental Health Assessment
Traditional psychiatric assessments frequently depend on clinical interviews and patient-reported symptoms. Digital biomarkers can complement these approaches by providing objective and continuous measurements of behavioral and physiological changes. This is increasing interest among healthcare professionals and researchers.
Technological Advancements in Artificial Intelligence
Artificial intelligence and machine learning technologies are increasingly being incorporated into digital biomarker platforms. Advanced algorithms can analyze large datasets collected from smartphones, wearable devices, and other digital technologies to identify behavioral patterns and potential indicators associated with psychiatric conditions.
Increasing Focus on Personalized Mental Healthcare
The growing emphasis on personalized medicine is creating opportunities for psychiatric digital biomarkers. Continuous patient data can help healthcare professionals better understand individual patterns and potentially support more personalized monitoring and treatment strategies.
Market Segmentation Analysis
Wearable Devices Hold Significant Market Potential
Based on technology, the market can be segmented into:
Wearable Devices
Smartphone-Based Technologies
Sensors
Other Digital Technologies
Wearable devices are expected to hold a significant market position due to their ability to continuously collect physiological and behavioral information, including activity levels, sleep patterns, heart rate, and other measurable parameters.
Depression and Anxiety Applications Drive Demand
Based on application, the market includes:
Depression
Anxiety Disorders
Bipolar Disorder
Schizophrenia
Other Psychiatric Disorders
The depression and anxiety segments are expected to witness strong demand due to the high prevalence of these conditions and increasing adoption of digital monitoring solutions.
Clinical Research and Drug Development Support Market Expansion
Digital biomarkers are increasingly being explored in clinical research and pharmaceutical drug development. Continuous digital data can provide researchers with additional insights into treatment response, patient behavior, and disease progression, supporting the development and evaluation of psychiatric therapies.
Healthcare Providers Increase Adoption
Healthcare providers are increasingly exploring digital solutions for remote monitoring and patient management. The integration of digital biomarkers into healthcare platforms could support more continuous engagement between patients and healthcare professionals.
Regional Insights
North America Leads the Global Market
North America is expected to maintain a significant position in the global Psychiatric Digital Biomarkers Market due to the growing adoption of digital health technologies, advanced healthcare infrastructure, increasing investments in mental health solutions, and strong presence of technology and healthcare companies.
The U.S. remains a major contributor to regional growth due to increasing digital healthcare adoption and growing research activities focused on psychiatric digital biomarkers.
Europe Experiences Strong Growth
Europe is witnessing increasing adoption of digital health technologies and growing investments in mental healthcare. Rising awareness regarding mental health and increasing research into digital biomarkers are expected to support regional market expansion.
Asia Pacific Shows Significant Growth Potential
Asia Pacific is expected to experience substantial growth during the forecast period due to increasing healthcare digitization, expanding smartphone adoption, improving healthcare infrastructure, and growing awareness of mental health conditions.
Countries such as China, Japan, India, and South Korea are increasingly adopting digital healthcare technologies, creating opportunities for psychiatric digital biomarker solutions.
Competitive Landscape
Leading companies and technology developers are focusing on developing innovative digital biomarker platforms, expanding research capabilities, strengthening collaborations with healthcare organizations, and integrating artificial intelligence into digital health solutions.
Major companies operating in or contributing to the Psychiatric Digital Biomarkers
Market include:
Biogen Inc.
Roche
Koneksa Health
Alto Neuroscience, Inc.
Mindstrong Health
Verily Life Sciences
Empatica Inc.
Apple Inc.
Recent Industry Developments
Companies continue investing in digital biomarker platforms for psychiatric and behavioral health applications.
Healthcare and technology organizations are increasing collaborations to develop advanced digital monitoring solutions.
Artificial intelligence and machine learning are increasingly being used to analyze behavioral and physiological data.
Researchers are exploring digital biomarkers for clinical trials, disease monitoring, and treatment response assessment.
Increasing investments in personalized mental healthcare are creating new opportunities for digital biomarker technologies.
Future Outlook
The future of the Psychiatric Digital Biomarkers Market appears highly promising. Increasing adoption of digital health technologies, rising awareness of mental health, growing demand for continuous monitoring, and advancements in artificial intelligence are expected to drive substantial market growth throughout the forecast period.
Companies focusing on advanced digital biomarker technologies, artificial intelligence, personalized healthcare solutions, clinical research partnerships, and secure data analytics are expected to strengthen their competitive position over the coming decade.
Request Sample Report:
ABOUT:
Fortune Business Insights™ provides strategic corporate analysis and precise data, assisting organizations of all sizes in making well-informed business decisions. Our reports combine comprehensive market studies with relevant data prepared by experienced analysts and consultants using industry-leading research tools and methodologies. We help organizations identify emerging opportunities and understand competitive market dynamics.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Phone:
U.S.: +1 833 909 2966 (Toll Free)
UK: +44 808 502 0280 (Toll Free)
APAC: +91 744 740 1245
Comments